Segments - Customized Medical Amblyopia Therapeutic Apparatus Market by Type (Icon Class Amblyopia Therapeutic Apparatus, Color Class amblyopia Therapeutic Apparatus, and Comprehensive Amblyopia Therapeutic Apparatus), Application (Vision Recovery Center, Eye Hospital, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global customized medical amblyopia therapeutic apparatus market size was valued at USD 66.2 million in 2022 and is likely to reach USD 91.01 million by 2031, expanding at a CAGR of 3.6% during 2023 – 2031. The growth of the market is attributed to increasing demand for vision impairment and amblyopia treatments and services.
Growing number of people experiencing vision impairments is resulting in rising demand for therapeutic apparatus or devices which further boosts the customized medical amblyopia therapeutic apparatus market. Vision impairments, including amblyopia or lazy eye, are becoming common due to increased screen time and digital device usage. This rise in patients creates a greater demand for amblyopia therapeutic devices that aid in treatment and recovery.
According to the report published by WHO on August 10, 2023, worldwide around 2.2 billion individuals are suffering from distance vision impairment.
Medical amblyopia therapeutic apparatuses known as amblyopia treatment devices are specialized tools. These tools are used in the medical domain to treat a condition recognized as amblyopia or lazy eye. Amblyopia constitutes a visual disorder characterized by diminished vision in one eye due to the brain's predilection for the other eye during developmental stages.
Therapeutic devices are carefully designed to detect and promote visual maturation in weak or lazy eyes. Typically, they incorporate specially crafted video games or visual stimuli delivered via goggles or eye patches. Furthermore, they have the capability to monitor and document the patient's progression over time, empowering healthcare practitioners to effectuate requisite modifications to the treatment regimen.
The COVID-19 pandemic moderately impacted the market. The pandemic disrupted the supply chain and manufacturing processes for these devices, leading to delays in production and distribution. Additionally, with healthcare systems strained by the pandemic, there was a temporary decrease in non-essential medical procedures, including amblyopia treatment which likely affected the demand for these therapeutic apparatuses.
The emergence of artificial intelligence (AI) contributes to market expansion. AI-powered diagnostic tools are improving the accuracy of amblyopia detection, allowing for earlier and precise identification of the condition in patients. Additionally, AI-driven personalized treatment plans are becoming common, tailoring therapeutic strategies to individual patient needs and progress.
Increasing incidence of vision-related conditions among the aged population is expected to drive the market. Amblyopia affects individuals of all ages. The growing number of people experiencing this condition contributes high demand for effective amblyopia treatment solutions, including customized medical amblyopia therapeutic apparatus. Moreover, growing awareness about these types of diseases led to the growth of the market.
According to the August 10, 2023 report by WHO, vision loss and impairment affect all age groups, but are most common among individuals over the age of 50.
High cost of therapeutic apparatuses for amblyopia is expected to hinder the market. These apparatuses often involve advanced technologies and specialized designs which makes them expensive. Moreover, the shortage of trained healthcare professionals to operate amblyopia therapeutic apparatus is further reducing their demand in the market.
Ongoing research and continuous innovation in technology are expected to create immense opportunities for the players competing in the market. Manufacturers are focusing on developing advanced and precise therapeutic apparatuses. They are incorporating artificial intelligence, digital tools, and adaptive features to improve the outcomes of amblyopia devices. Furthermore, the integration of telehealth and remote monitoring in these devices to treat remotely is boosting the market.
The report on the market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Customized Medical Amblyopia Therapeutic Apparatus Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Type (Icon Class Amblyopia Therapeutic Apparatus, Color Class amblyopia Therapeutic Apparatus, and Comprehensive Amblyopia Therapeutic Apparatus) and Application (Vision Recovery Center, Eye Hospital, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Animas; Insulet Corporation; Medtronic; Microlife Corporation; OMRON Corporation; Panasonic Corporation; Roche; and Siemens Healthcare GmbH |
Based on type, the customized medical amblyopia therapeutic apparatus market is divided into icon class amblyopia therapeutic apparatus, color class amblyopia therapeutic apparatus, and comprehensive amblyopia therapeutic apparatus.
The icon class amblyopia therapeutic apparatus segment is expected to hold a major market revenue share during the forecast period, due to the rising number of patients suffering from vision impairments and amblyopia. Icon-class amblyopia therapeutic apparatus used for unique vision challenges associated with icon-class amblyopia. This precision is important for positive treatment outcomes. Moreover, advances to improve the effectiveness of icon-class amblyopia therapeutic apparatus further fuel their market growth.
The color class amblyopia therapeutic apparatus segment is anticipated to register robust growth in the market, as this apparatus is specifically designed for color-related vision issues. This therapeutic apparatus makes treatment highly effective which is important particularly for amblyopia. Additionally, tailored treatment regimens offered by icon class apparatus to achieve successful outcomes further boost their demand in the market.
In terms of application, the customized medical amblyopia therapeutic apparatus market is fragmented into vision recovery center, eye hospital, and others. The eye hospital segment is expected to hold a key market share during the projected period, owing to better diagnose and treatment options for vision disorders or amblyopia.
These hospitals have the necessary expertise to accurately diagnose amblyopia and recommend suitable treatment options. Furthermore, eye hospitals offer a wide range of amblyopia treatment options which further contributes to fuel the growth of this segment in the market.
The vision recovery centers segment is projected to register a considerable CAGR during the forecast period, due to the increasing number of these types of healthcare settings. These centers offer customized treatment plans leading to a rise in the number of patients seeking their services.
They conduct detailed assessments and use specialized equipment for better patient outcomes. Moreover, the easy accessibility of vision recovery centers to patients has further contributed to the growth of this segment in the market.
In terms of region, the global customized medical amblyopia therapeutic apparatus market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market, due to its highly developed and sophisticated healthcare facilities, including modern eye clinics and hospitals.
This advanced infrastructure supports the adoption and utilization of cutting-edge therapeutic apparatus for amblyopia treatment. Moreover, the growing population suffering from vision impairments and amblyopia further propels the demand for therapeutic apparatus in the market.
As per the report published by the Centers for Disease Control and Prevention on December 19, 2022, roughly 12 million Americans aged 40 years or above are suffering from vision impairment. Additionally, nearly 6.8% of children below the age of 18 in the United States have been diagnosed with eye and vision conditions.
The market in Asia Pacific is anticipated to expand at a rapid pace in the coming years, due to increasing healthcare investment. Many countries in the Asia Pacific region are investing in their healthcare infrastructure and technologies. This investment facilitates the adoption of advanced medical devices, including amblyopia therapeutic apparatus. Moreover, the rapidly growing population with amblyopia or other vision diseases further boosts the market.
The global customized medical amblyopia therapeutic apparatus market has been segmented on the basis of
Key players competing in the global customized medical amblyopia therapeutic apparatus market are Animas; Insulet Corporation; Medtronic; Microlife Corporation; OMRON Corporation; Panasonic Corporation; Roche; and Siemens Healthcare GmbH
These companies are fueling their market share by implementing various strategies such as mergers, and partnerships, launching new products, reducing production costs, and implementing advanced technologies.